ÂÜÀòÂÒÂ×

Dr. Brandon Zipp is the CSO and Scientific Co-founder of Vitality Biopharma, Inc. He is a developer and inventor of the company’s cannaboside compounds, a class of cannabinoid compounds that have been modified through enzymatic glycosylation, and which enables targeting to the gastrointestinal tract. He has diverse training in biochemistry, molecular biology, and fermentation, combined with 15 years of research experience with plant glucosyltransferases, the enzymes that enable production of cannabosides. Dr. Zipp received his Ph.D. in Biochemistry and Molecular Biology from the University of California at Davis in 2013.